From: Role of fecal calprotectin as a hypoxic intestinal damage biomarker in COVID-19 patients
P/F Ratio (mmHg) | Total (n = 44) | FC-negative (< 50) (n = 26) | FC-positive (≥ 50) (n = 18) |
---|---|---|---|
Mean ± SD | 312.18 ± 137.78 | 396.19 ± 100.45 | 190.83 ± 82.41 |
P/F Ratio ≤ 100 (Severe ARDS) | 2 (4.54%) | 0 (0%) | 2 (11.11) |
100 < P/F Ratio ≤ 200 (Moderate ARDS) | 10 (22.72%) | 1 (3.85%) | 9 (50%) |
200 < P/F Ratio ≤ 300 (Mild ARDS) | 10 (22.72%) | 4 (15.39%) | 6 (33.33%) |
P/F Ratio > 300 (Non-ARDS) | 22 (50%) | 21 (80.77%) | 1 (5.56%) |